CERN Accelerating science

NEWS!

• 09/2024

CERN hosted the 21st Plenay Meeting of the European Observatory on the the Supply of Medical Radionuclides on 25 and 26 of September 2024.

• 08/2024

Metrology related to medical radioisotopes and MEDICIS is part of the 70^th anniversary of CERN-UK relationship celebration on 21^st August at NPL.

 

• 04/2024

The facility restarts for 2024!

• 02/2024

David Townsend, co-inventor of the PET-CT visited MEDICIS

​​

• 11/2023

Peter Thomson CEO of NPL and colleagues visited MEDICIS and discussed on the metrological aspects important for medical isotopes.

• 10/2023

The five-years MEDICIS programme and operation was very successfully reviewed by a CERN international review panel.

• 06/2023

MEDICIS recent achievements have been presented during invited presentations at the ARIS2023 conference (Avignon, France) and the 16th conference on nuclear reaction mechanisms (Varenna, Italy)

• 16/05/2023

Recent technical developments such as the online activity monitoring during implantation and the definition of Key Performance Indicators for MEDICIS were reported at EMIS2022 and IPAC2023 conferences. Related EMIS and IPAC publications.

• 10/03/2023

Three new project proposals were submitted at the 10th MEDICIS Collaboration board, with a notable request to translate one of the MEDICIS High Molar Activity radionuclides in a clinical settings.

• 15/11/2022

The Frontiers Research Topics : MEDICIS-Promed, Advances in Radioactive Ion Beams for Nuclear Medicine is now published. It can be downloaded from there.

• 26/09/2022

The half-life of Tb-155 produced at MEDICIS has been revised and is now published by S. Collins et al. in Applied Radiation and Isotope. High molar activity Sm-153 was 1st used in Targeted Radionuclide Therapy and theranostics (MED-025) by M. Ooms et al, as presented at TERACHEM.

 

JOB OPPORTUNITIES

• Applied physicist or engineer staff in directorate's office, expertise in particle accelerator technologies and international collaborations, to identify and develop CERN accelerator technology for societal benefit, with a focus on medical fields; more information and to apply click here. ope.